Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment

[1]  D. Edwards,et al.  Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent , 2021, Drug Safety.

[2]  S. W. Asgedom,et al.  Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study , 2020, BMC Pregnancy and Childbirth.

[3]  Yohanes Ayele,et al.  Prescription drugs use during pregnancy in Ethiopia: A systematic review and meta-analysis , 2020, SAGE open medicine.

[4]  A. Cantarutti,et al.  Use and Intentional Avoidance of Prescribed Medications in Pregnancy: A Cross-Sectional, Web-Based Study among 926 Women in Italy , 2020, International journal of environmental research and public health.

[5]  N. Tiffin,et al.  Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa , 2019, International journal of population data science.

[6]  L. Myer,et al.  Long-term outcomes of HIV-infected women receiving antiretroviral therapy after transferring out of an integrated maternal and child health service in South Africa. , 2019, Journal of acquired immune deficiency syndromes.

[7]  Paul A. Harris,et al.  The REDCap consortium: Building an international community of software platform partners , 2019, J. Biomed. Informatics.

[8]  J. Norman,et al.  Medicines in pregnancy , 2019, F1000Research.

[9]  H. Rees,et al.  Why South Africa urgently needs to support the development of pregnancy exposure registries. , 2019, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[10]  M. Loane,et al.  First trimester medication use in pregnancy in Cameroon: a multi-hospital survey , 2018, BMC Pregnancy and Childbirth.

[11]  A. Moosavi,et al.  Prevalence and Reasons of Self-Medication in Pregnant Women: A Systematic Review and Meta-Analysis , 2018, International journal of community based nursing and midwifery.

[12]  C. Proust-Lima,et al.  Different latent class models were used and evaluated for assessing the accuracy of campylobacter diagnostic tests: overcoming imperfect reference standards? , 2018, Epidemiology and Infection.

[13]  A. Boulle,et al.  Assessing the value of Western Cape Provincial Government health administrative data and electronic pharmacy records in ascertaining medicine use during pregnancy , 2018, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[14]  R. Xu,et al.  Agreement Between Maternal Report and Medical Records During Pregnancy: Medications for Rheumatoid Arthritis and Asthma , 2018, Paediatric and perinatal epidemiology.

[15]  Kenneth Beath,et al.  randomLCA: An R Package for Latent Class with Random Effects Analysis , 2017 .

[16]  F. Barbone,et al.  Medication use during pregnancy, gestational age and date of delivery: agreement between maternal self-reports and health database information in a cohort , 2015, BMC Pregnancy and Childbirth.

[17]  Edwin Were,et al.  Influences on participant reporting in the World Health Organisation drugs exposure pregnancy registry; a qualitative study , 2014, BMC Health Services Research.

[18]  S. Abdulla,et al.  Medication exposure during pregnancy: a pilot pharmacovigilance system using health and demographic surveillance platform , 2014, BMC Pregnancy and Childbirth.

[19]  J. Reitsma,et al.  Latent class models in diagnostic studies when there is no reference standard--a systematic review. , 2014, American journal of epidemiology.

[20]  A. Gilbert,et al.  Investigating outcomes associated with medication use during pregnancy: a review of methodological challenges and observational study designs. , 2012, Reproductive toxicology.

[21]  Devon L. Greyson,et al.  Prescription drug use during pregnancy in developed countries: a systematic review , 2011, Pharmacoepidemiology and drug safety.

[22]  K. Yusuff,et al.  Determinants of self medication practices among pregnant women in Ibadan, Nigeria , 2011, International Journal of Clinical Pharmacy.

[23]  T. Bjørge,et al.  Comparison of recorded medication use in the Medical Birth Registry of Norway with prescribed medicines registered in the Norwegian Prescription Database , 2011, Pharmacoepidemiology and drug safety.

[24]  F. Granath,et al.  Drug use during pregnancy in Sweden – assessed by the Prescribed Drug Register and the Medical Birth Register , 2011, Clinical epidemiology.

[25]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[26]  I. Guissou,et al.  Prescription drugs among pregnant women in Lome, Togo, West Africa , 2009, European Journal of Clinical Pharmacology.

[27]  E. Hansen,et al.  Agreement between self-reported data on medicine use and prescription records vary according to method of analysis and therapeutic group. , 2008, Journal of clinical epidemiology.

[28]  L. Jong‐van den Berg,et al.  Drug use in pregnancy: A comparative appraisal of data collecting methods , 2004, European Journal of Clinical Pharmacology.

[29]  E. Gharoro,et al.  Pattern of drug use amongst antenatal patients in Benin City, Nigeria. , 2000, Medical science monitor : international medical journal of experimental and clinical research.

[30]  I. Cope.  Medicines in pregnancy , 1991, The Medical journal of Australia.

[31]  J. R. Landis,et al.  The measurement of observer agreement for categorical data. , 1977, Biometrics.